Pioneering Intranasal Delivery of Novel Biologics to Unlock New Therapeutic Opportunities
11:30 am - Thursday 4th February 2027
- Explore how next-generation biologic modalities can overcome traditional delivery barriers to enable effective intranasal administration while maintaining therapeutic activity
- Understand how intranasal biologics can leverage local mucosal immunity to provide differentiated therapeutic benefits across infectious disease and other emerging applications
- Learn from the development of novel biologic platforms and the scientific, translational, and regulatory considerations required to progress these therapies toward clinical success
